MedTrace Logo

HemoPill Acute ® in Suspected Nonvariceal Upper Gastrointestinal Bleeding

NCT04472364 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 73

Last updated 2024-07-10

No results posted yet for this study

Summary

The study examines, whether the use of the HemoPill Acute ® capsule in case of suspected nonvariceal upper gastrointestinal bleeding can identify cases in which endoscopy can be delayed to 48-96 hours without risk to the patient.

Conditions

  • Upper Gastrointestinal Bleeding

Interventions

DEVICE

HemoPill Acute ®

Capsule positive: Endoscopy endoscopy will be performed within 12 hours. Capsule negative: Endoscopy will be performed after 48 to 96 hours.

Sponsors & Collaborators

  • Vivantes Netzwerk für Gesundheit GmbH

    collaborator OTHER

  • University Hospital Freiburg

    collaborator OTHER

  • Sana Klinikum Offenbach

    collaborator OTHER

  • Wuerzburg University Hospital

    lead OTHER

Principal Investigators

  • Alexander Meining, Prof. Dr. · Universital Hospital Würzburg

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-08
Primary Completion
2024-04-08
Completion
2024-04-08

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04472364 on ClinicalTrials.gov